Results per Page:
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies
Tackling an aggressive form of pancreatic cancer
Dr. Stephanie Dobersch awarded American Cancer Society Fellowship to study genetics of basal pancreatic adenocarcinoma
Pancreatic ductal adenocarcinoma subtypes: what your type means?
From the Kugel Lab, Human Biology Division
Degrade, degrade oncoproteins! PROTACs, a new strategy to kill cancer cells
From the Nabet Lab, Human Biology Division
Functionalizing the genome to find novel pancreatic cancer treatments
From the Kemp Lab, Human Biology Division
Hutchinson Center scientists break through pancreas cancer treatment barrier
Research study reports extending survival in mice by 70 percent; initial studies in humans are under way